David founded bio-Growth, LLC, to help life science companies and their investors with corporate development, new market assessment, and business planning, which is what he has done at companies like Edison Agrosciences, Blue Praire, and Chromatin, Inc. and organizations like the Federal Reserve Bank of Chicago. Prior to this, David was a sell-side research analyst for 10 years, most recently publishing investment research on companies in the areas of alternative fuels and water technology for boutique investment bank ThinkEquity. Earlier, David provided research coverage of Specialty/Generic Pharma and Global Pharma for Prudential’s institutional equity business, being named in the Wall Street Journal’s Best of the Street survey and frequently being quoted by Barrons, Reuters, Dow Jones, The New York Times, the Boston Globe, and others.
David's eleven years of healthcare industry experience include corporate strategy and merger integration at Searle Pharmaceuticals, and product design, global marketing, and business development within various divisions of Baxter Healthcare. David remains a co-owner of a Midwestern grain farm, Maplewood Farm, LLC. David is a graduate of the University of Chicago’s Booth School of Business, and holds a B.S. in Mechanical Engineering from the University of Illinois at Urbana-Champaign.
Copyright © 2021 bio-Growth, LLC - All Rights Reserved.